AS
Aspen Aerogels, Inc.
ASPN · NYSE
$4.84 -1.53% (-$0.08)
1M -15.64%
Market Cap $406.9M
P/E Ratio -
Div. Yield -
ROE 53.29%
Bulios Fair Price
$5.46
12.9% upside
Current Price
$4.84
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ASPN is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
79 /100
Cheap P/S 2.01x
P/B 2.11x
P/FCF 10.84x
Growth
76 /100
Growing Rev. growth 14.55%
Book val. growth 19.26%
EPS growth N/A
Profitability
60 /100
Moderate Gross margin 2.68%
Net margin 62.45%
FCF margin 18.58%
Quality
48 /100
Average ROIC 60.71%
ROE 53.29%
Asset turnover 0.51x
Debt
62 /100
Moderate Debt/Equity 0.65x
Current ratio 2.52x
Int. coverage -22.65x
Stability
5 /100
Unstable Beta 2.97x
Rev. volatility 65.02%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ASPN
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Donald R. Young
Employees
854
Headquarters
Northborough
Upcoming events
05 NOV
Earnings
Upcoming earnings report